* Aethlon Medical Inc AEMD.OQ reported a quarterly
adjusted loss
of 13 cents per share for the quarter ended December 31,
higher than the same quarter last year, when the company
reported EPS of $-1.37. The mean expectation of three analysts
for the quarter was for a loss of 21 cents per share. Wall
Street expected results to range from -23 cents to -20 cents per
share.
* Reported revenue was zero; analysts expected zero.
* Aethlon Medical Inc's reported EPS for the quarter was a
loss
of 13 cents.
* The company reported a quarterly loss of $1.75 million.
* Aethlon Medical Inc shares had fallen by 20.7% this
quarter.
FORECAST CHANGES
* The mean earnings estimate of analysts had risen by
about 0.8%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the advanced
medical
equipment & technology peer group is "hold."
Wall Street's median 12-month price target for Aethlon Medical
Inc is $3.86
This summary was machine generated from LSEG data February 12 at
11:38 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2024 -0.21 -0.13 Beat
Sep. 30 2024 -0.19 -0.20 Missed
Jun. 30 2024 -0.31 -0.34 Missed
Mar. 31 2024 -1.23 -0.91 Beat